AstraZeneca Blames 'Toxic' Climate As It Walks Away from Over $550 Million UK Vaccine Plant

AstraZeneca Plc (NASDAQ:AZN) has abandoned plans for a $554.32 million (450 million pounds) vaccine manufacturing facility in the U.K. following disagreements with government officials over state support, marking a setback for Prime Minister Sir Keir Starmer's administration.

In August 2024, AstraZeneca reconsidered its planned investment in a new vaccine-manufacturing site, a departure from CEO Pascal Soriot's previous statement that the company was "absolutely ready to go."

Also Read: FDA Approves AstraZeneca, Daiichi Sankyo's Enhertu For Certain Type Of Breast Cancer Patients

The U.K. Treasury, under the direction of Rachel Reeves, is reportedly considering decreasing government support for AstraZeneca by over 20 million pounds.

As a result, AstraZeneca said it might relocate the project from Speke in ...

Full story available on Benzinga.com